Copyright Reports & Markets. All rights reserved.

Global Premature Ejaculation Treatment Drug Market Growth (Status and Outlook) 2023-2029

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Premature Ejaculation Treatment Drug Market Size 2018-2029
    • 2.1.2 Premature Ejaculation Treatment Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 Premature Ejaculation Treatment Drug Segment by Type
    • 2.2.1 Selective Serotonin Reuptake Inhibitor
    • 2.2.2 Tricyclic Antidepressant
    • 2.2.3 Topical Anesthetic Agent
    • 2.2.4 Phosphodiesterase 5 Inhibitors
    • 2.2.5 Others
  • 2.3 Premature Ejaculation Treatment Drug Market Size by Type
    • 2.3.1 Premature Ejaculation Treatment Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global Premature Ejaculation Treatment Drug Market Size Market Share by Type (2018-2023)
  • 2.4 Premature Ejaculation Treatment Drug Segment by Application
    • 2.4.1 Under 25 Years Old
    • 2.4.2 25 to 40 Years Old
    • 2.4.3 40 to 55 years old
    • 2.4.4 Over 55 Years Old
  • 2.5 Premature Ejaculation Treatment Drug Market Size by Application
    • 2.5.1 Premature Ejaculation Treatment Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global Premature Ejaculation Treatment Drug Market Size Market Share by Application (2018-2023)

3 Premature Ejaculation Treatment Drug Market Size by Player

  • 3.1 Premature Ejaculation Treatment Drug Market Size Market Share by Players
    • 3.1.1 Global Premature Ejaculation Treatment Drug Revenue by Players (2018-2023)
    • 3.1.2 Global Premature Ejaculation Treatment Drug Revenue Market Share by Players (2018-2023)
  • 3.2 Global Premature Ejaculation Treatment Drug Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Premature Ejaculation Treatment Drug by Regions

  • 4.1 Premature Ejaculation Treatment Drug Market Size by Regions (2018-2023)
  • 4.2 Americas Premature Ejaculation Treatment Drug Market Size Growth (2018-2023)
  • 4.3 APAC Premature Ejaculation Treatment Drug Market Size Growth (2018-2023)
  • 4.4 Europe Premature Ejaculation Treatment Drug Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa Premature Ejaculation Treatment Drug Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas Premature Ejaculation Treatment Drug Market Size by Country (2018-2023)
  • 5.2 Americas Premature Ejaculation Treatment Drug Market Size by Type (2018-2023)
  • 5.3 Americas Premature Ejaculation Treatment Drug Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Premature Ejaculation Treatment Drug Market Size by Region (2018-2023)
  • 6.2 APAC Premature Ejaculation Treatment Drug Market Size by Type (2018-2023)
  • 6.3 APAC Premature Ejaculation Treatment Drug Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Premature Ejaculation Treatment Drug by Country (2018-2023)
  • 7.2 Europe Premature Ejaculation Treatment Drug Market Size by Type (2018-2023)
  • 7.3 Europe Premature Ejaculation Treatment Drug Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Premature Ejaculation Treatment Drug by Region (2018-2023)
  • 8.2 Middle East & Africa Premature Ejaculation Treatment Drug Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa Premature Ejaculation Treatment Drug Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Premature Ejaculation Treatment Drug Market Forecast

  • 10.1 Global Premature Ejaculation Treatment Drug Forecast by Regions (2024-2029)
    • 10.1.1 Global Premature Ejaculation Treatment Drug Forecast by Regions (2024-2029)
    • 10.1.2 Americas Premature Ejaculation Treatment Drug Forecast
    • 10.1.3 APAC Premature Ejaculation Treatment Drug Forecast
    • 10.1.4 Europe Premature Ejaculation Treatment Drug Forecast
    • 10.1.5 Middle East & Africa Premature Ejaculation Treatment Drug Forecast
  • 10.2 Americas Premature Ejaculation Treatment Drug Forecast by Country (2024-2029)
    • 10.2.1 United States Premature Ejaculation Treatment Drug Market Forecast
    • 10.2.2 Canada Premature Ejaculation Treatment Drug Market Forecast
    • 10.2.3 Mexico Premature Ejaculation Treatment Drug Market Forecast
    • 10.2.4 Brazil Premature Ejaculation Treatment Drug Market Forecast
  • 10.3 APAC Premature Ejaculation Treatment Drug Forecast by Region (2024-2029)
    • 10.3.1 China Premature Ejaculation Treatment Drug Market Forecast
    • 10.3.2 Japan Premature Ejaculation Treatment Drug Market Forecast
    • 10.3.3 Korea Premature Ejaculation Treatment Drug Market Forecast
    • 10.3.4 Southeast Asia Premature Ejaculation Treatment Drug Market Forecast
    • 10.3.5 India Premature Ejaculation Treatment Drug Market Forecast
    • 10.3.6 Australia Premature Ejaculation Treatment Drug Market Forecast
  • 10.4 Europe Premature Ejaculation Treatment Drug Forecast by Country (2024-2029)
    • 10.4.1 Germany Premature Ejaculation Treatment Drug Market Forecast
    • 10.4.2 France Premature Ejaculation Treatment Drug Market Forecast
    • 10.4.3 UK Premature Ejaculation Treatment Drug Market Forecast
    • 10.4.4 Italy Premature Ejaculation Treatment Drug Market Forecast
    • 10.4.5 Russia Premature Ejaculation Treatment Drug Market Forecast
  • 10.5 Middle East & Africa Premature Ejaculation Treatment Drug Forecast by Region (2024-2029)
    • 10.5.1 Egypt Premature Ejaculation Treatment Drug Market Forecast
    • 10.5.2 South Africa Premature Ejaculation Treatment Drug Market Forecast
    • 10.5.3 Israel Premature Ejaculation Treatment Drug Market Forecast
    • 10.5.4 Turkey Premature Ejaculation Treatment Drug Market Forecast
    • 10.5.5 GCC Countries Premature Ejaculation Treatment Drug Market Forecast
  • 10.6 Global Premature Ejaculation Treatment Drug Forecast by Type (2024-2029)
  • 10.7 Global Premature Ejaculation Treatment Drug Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Absorption Pharmaceuticals
    • 11.1.1 Absorption Pharmaceuticals Company Information
    • 11.1.2 Absorption Pharmaceuticals Premature Ejaculation Treatment Drug Product Offered
    • 11.1.3 Absorption Pharmaceuticals Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Absorption Pharmaceuticals Main Business Overview
    • 11.1.5 Absorption Pharmaceuticals Latest Developments
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Company Information
    • 11.2.2 AstraZeneca Premature Ejaculation Treatment Drug Product Offered
    • 11.2.3 AstraZeneca Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 AstraZeneca Main Business Overview
    • 11.2.5 AstraZeneca Latest Developments
  • 11.3 Allergan, Plc
    • 11.3.1 Allergan, Plc Company Information
    • 11.3.2 Allergan, Plc Premature Ejaculation Treatment Drug Product Offered
    • 11.3.3 Allergan, Plc Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 Allergan, Plc Main Business Overview
    • 11.3.5 Allergan, Plc Latest Developments
  • 11.4 Bayer AG
    • 11.4.1 Bayer AG Company Information
    • 11.4.2 Bayer AG Premature Ejaculation Treatment Drug Product Offered
    • 11.4.3 Bayer AG Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Bayer AG Main Business Overview
    • 11.4.5 Bayer AG Latest Developments
  • 11.5 Eli Lilly & Company
    • 11.5.1 Eli Lilly & Company Company Information
    • 11.5.2 Eli Lilly & Company Premature Ejaculation Treatment Drug Product Offered
    • 11.5.3 Eli Lilly & Company Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 Eli Lilly & Company Main Business Overview
    • 11.5.5 Eli Lilly & Company Latest Developments
  • 11.6 GlaxoSmithkline, Plc
    • 11.6.1 GlaxoSmithkline, Plc Company Information
    • 11.6.2 GlaxoSmithkline, Plc Premature Ejaculation Treatment Drug Product Offered
    • 11.6.3 GlaxoSmithkline, Plc Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 GlaxoSmithkline, Plc Main Business Overview
    • 11.6.5 GlaxoSmithkline, Plc Latest Developments
  • 11.7 Innovus Pharmaceutical
    • 11.7.1 Innovus Pharmaceutical Company Information
    • 11.7.2 Innovus Pharmaceutical Premature Ejaculation Treatment Drug Product Offered
    • 11.7.3 Innovus Pharmaceutical Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Innovus Pharmaceutical Main Business Overview
    • 11.7.5 Innovus Pharmaceutical Latest Developments
  • 11.8 Merck & Co., Inc.
    • 11.8.1 Merck & Co., Inc. Company Information
    • 11.8.2 Merck & Co., Inc. Premature Ejaculation Treatment Drug Product Offered
    • 11.8.3 Merck & Co., Inc. Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Merck & Co., Inc. Main Business Overview
    • 11.8.5 Merck & Co., Inc. Latest Developments
  • 11.9 Pfizer, Inc.
    • 11.9.1 Pfizer, Inc. Company Information
    • 11.9.2 Pfizer, Inc. Premature Ejaculation Treatment Drug Product Offered
    • 11.9.3 Pfizer, Inc. Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.9.4 Pfizer, Inc. Main Business Overview
    • 11.9.5 Pfizer, Inc. Latest Developments
  • 11.10 Teva Pharmaceutical Industries Ltd.
    • 11.10.1 Teva Pharmaceutical Industries Ltd. Company Information
    • 11.10.2 Teva Pharmaceutical Industries Ltd. Premature Ejaculation Treatment Drug Product Offered
    • 11.10.3 Teva Pharmaceutical Industries Ltd. Premature Ejaculation Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 11.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
    • 11.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments

12 Research Findings and Conclusion

The global Premature Ejaculation Treatment Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Premature Ejaculation Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Premature Ejaculation Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Premature Ejaculation Treatment Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Premature Ejaculation Treatment Drug players cover Absorption Pharmaceuticals, AstraZeneca, Allergan, Plc, Bayer AG, Eli Lilly & Company, GlaxoSmithkline, Plc, Innovus Pharmaceutical, Merck & Co., Inc. and Pfizer, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Premature Ejaculation Treatment Drug Industry Forecast” looks at past sales and reviews total world Premature Ejaculation Treatment Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Premature Ejaculation Treatment Drug sales for 2023 through 2029. With Premature Ejaculation Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Premature Ejaculation Treatment Drug industry.

This Insight Report provides a comprehensive analysis of the global Premature Ejaculation Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Premature Ejaculation Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Premature Ejaculation Treatment Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Premature Ejaculation Treatment Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Premature Ejaculation Treatment Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Premature Ejaculation Treatment Drug market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Selective Serotonin Reuptake Inhibitor
Tricyclic Antidepressant
Topical Anesthetic Agent
Phosphodiesterase 5 Inhibitors
Others

Segmentation by application
Under 25 Years Old
25 to 40 Years Old
40 to 55 years old
Over 55 Years Old

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Absorption Pharmaceuticals
AstraZeneca
Allergan, Plc
Bayer AG
Eli Lilly & Company
GlaxoSmithkline, Plc
Innovus Pharmaceutical
Merck & Co., Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.

Buy now